Annual Report Searches
Alphabetical Search



Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds and ACD's in situ hybridization detection products --- which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotechnology Division, headquartered in Minneapolis, Minnesota. The Protein Platforms Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM customer and clinical customers. Bio-Techne products are integral components of scientific investigations into biological processes and the nature, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means to develop accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $643 million in net sales in fiscal 2018 and has over 2,100 employees worldwide.

Yearly Figures
(in thousands, except per share amounts)
FYE: 6/30 2018 2017 2016 2015
Net Revenues $642,993 $563,003 $499,023 $452,246
Net Income $125,350 $76,086 $104,476 $107,735
Earnings Per Share 3.29 2.03 2.80 2.89
Quarterly Figures
(in thousands, except per share amounts)
              Second Quarter
FYE: 6/30 12/31/18 12/31/17
Net Revenues $174,510 $154,153
Net Income $17,556 $48,847
Earnings Per Share 0.45 1.29
Contact Information
Contact Name: Kathy Backes
Contact Title: Controller
Phone: (800) 328-2400